chrisvoncsefalvay/vaers-outcomes huggingface dataset:
stinging pain; large protrusion size of half egg, not solid; salivating; poor gait; weak; swelling, large protrusion size of half egg; rash; tender and sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (stinging pain), VACCINATION SITE MASS (large protrusion size of half egg, not solid), SALIVARY HYPERSECRETION (salivating), GAIT DISTURBANCE (poor gait) and ASTHENIA (weak) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    The patient's past medical history included No adverse event (No medical history was provided.).   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient started ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN (stinging pain), VACCINATION SITE MASS (large protrusion size of half egg, not solid), SALIVARY HYPERSECRETION (salivating), GAIT DISTURBANCE (poor gait), ASTHENIA (weak), SWELLING (swelling, large protrusion size of half egg), RASH (rash) and VACCINATION SITE PAIN (tender and sore). At the time of the report, PAIN (stinging pain), VACCINATION SITE MASS (large protrusion size of half egg, not solid), SALIVARY HYPERSECRETION (salivating), GAIT DISTURBANCE (poor gait), ASTHENIA (weak), SWELLING (swelling, large protrusion size of half egg), RASH (rash) and VACCINATION SITE PAIN (tender and sore) outcome was unknown.            This case was linked to MOD-2021-051626 (Patient Link).   Reporter did not allow further contact
Pain & tingling in (L) arm from shoulder down through fingers. (L) arm swelling with rash.
Itchy at injection site, random rashes through my body that would come and go.  Sore throat and and sore chest developed  4 days after injection.
woke up during the night after her second dose (dose given on Friday) with joint pain (around midnight or shortly after); joint pain; intense fatigue; muscle aches; arm was sore at the injection site; This is a spontaneous report from a contactable other healthcare professional (patient). A 40-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration (left arm) on 08Jan2021 (11:00) at single dose for Covid-19 immunization. The patient received the first dose of BNT162B2 (lot number: EH9899) on 18Dec2020 (02:45 PM) via an unspecified route (right arm) for Covid-19 immunization. The patient's medical history included drug allergy (reported as known allergies: Cephalosporin (mild reaction of hives one time after having taken it with no issues for years-pending clarification)). There were no concomitant medications. The patient was not diagnosed with COVID-19 prior to vaccination. The patient reported that she woke up during the night after her second dose (dose given on Friday) with joint pain (around midnight or shortly after [09Jan2021, 12:15AM]). The entire day after her 2nd dose (during the day Saturday) every joint in her body ached and she experienced intense fatigue. There were also some muscle aches in her shoulders and her arm was sore at the injection site as it usually is after a tetanus shot (she stated she had soreness in her arm the day after the first injection but no other adverse events after the first injection). She did not seek medical treatment and did not take any over the counter medications to alleviate the symptoms as she does not typically take medications unless absolutely necessary. By the next day (Sunday), she was much better and had only slight joint pain remaining in her neck. By the following day (Monday;11Jan2021), all symptoms had resolved. She further stated that the symptoms experienced for one day did not make her regret getting the vaccine and she continue to strongly recommend the vaccine. The outcome of events was recovered on 11Jan2021. The patient has not been tested for COVID-19 since the vaccination.
Narrative: COVID infections following completion of COVID vaccine series 06/11/21 COVID vaccine dose #1 (J&J) 07/31/21 Pt presents for preop COVID test with no symptoms - COVID POSITIVE 08/01/21 Pt remains asymptomatic 08/05/21 Pt reports tiredness, mild muscle aches, and mild headaches 08/17/21 Pt released from quarantine; reports he is gradually and progressively feeling improved currently is only residual symptom is fatigue and mild achiness
Red, itchy rash at injection site. Started 8 days after vaccine, increasingly worsening until day 12 after vaccine. Initially started about the size of a dime. Got to 6 x 6  inches with a raised red edge. After day 12 gradually improved. Now at day 26, still have a small red itchy patch at site of injection surrounded by a slightly larger discolored patch that is lighter than the skin around it.
patient received the 3rd vaccine too early spoke to parent patient hasnt had any s/s or adverse reactions
Patient states flu like symptoms that started 24 hours after booster shot. States she had extreme body aches skin sensitivity all over her body and chills that resolved in 24 hours with tylenol use.
pt recv vax & 2 days post vax devel hives & itching;this is one of four patients from this site who exp above rxn;
Fever not exceeding 100. Severe fatigue. Symptoms subsided approximately 42 hours later.
Information has been received from a medical assistance concerning a multiple unspecified patients of unknown ages and genders. The patients' pertinent medical history and concurrent conditions were not informed. On an unknown dates, the patients were administered improperly stored doses of PNEUMOVAX 23 lot # L031459, expiration date 30-APR-2017, (dosages and therapy routes were not provided). Concomitant therapies were not informed. No adverse effects were reported. The medical assistant reported that the vaccine was exposed to a temperature of 51F for hour and 30 minutes and then was also exposed to a temperature of 48F during an hour and that this information was obtained with a digital data logger. Finally, no product quality complaint was involved. This is one of several reports received from the same source. Additional information is not expected as no consent for follow up was given.
Injection site became red and swollen with a white ring around the area.  This would "calm down" and then flare up again in a couple of hours.  Now 2 weeks later the patient reports that there is some skin sloughing of the area.
Fever for 8 days.  Fever ranging 100.4 -104 axillary.
Fever (102,1 °F); Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever (102,1 °F)), CHILLS (Chills) and FATIGUE (Fatigue) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048F71A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL for Hypertension.    On 09-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Sep-2021, the patient experienced PYREXIA (Fever (102,1 °F)), CHILLS (Chills) and FATIGUE (Fatigue). At the time of the report, PYREXIA (Fever (102,1 °F)), CHILLS (Chills) and FATIGUE (Fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.2 (High) 101,2 °F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Patient c/o nausea, dizziness shortly after immunizations were administered.  Patient was assisted to prone position (laying down) with icepack applied to neck area.
Lips started itchy at the time of vaccination.  Later that day I started having shortness of breathe and racing heart rate. Went to the ER continued to have racing heart rate for 2 weeks. I had cold sweats, fatigue, shortness of breathe.  Still having racing heart rate. Had to be put on medication to slow heart rate down.
generalized itching 3 days after first vaccine given follow by drug rash in different parts of body starting one week after vaccine and persisting to today 2/4/2021
Fever beginning afternoon of 8/26/07 - 102.9. Other symptoms headache, listless, no appetite. Mother has been giving oral Tylenol. Fever present off and on this week - 102.7 on AM of 8/31/07. Vomited x2 on 8/27. Diarrhea 8/31. Mother consulted doctor by phone.
Joint pain, swelling, synovitis within 24 hours of administration of vaccine.  RA Factor positive on 6/30/08.  Patient is missing multiple days of work due to symptoms. Patient recently changed primary care physicians and we have been unable to access information regarding lot number and manufacturer of vaccine, date of vaccination.  please contact Dr. for information.
Yes got very painful at night and upon wakening.  In the morning they were very puzzled and red.  Put Systane eye drops in a couple of time during the day and also put ice pack on eyes which helped.  Definitely something going on with my eyes.  I never use eye drops or have to put ice on my eyes.  Hopefully will be better soon but wanted it noted.
Sore throat (hard to swallow), vomiting, and red splotches all over body, hives, itching, shaking all over.
Janssen COVID-19 Vaccine EUA I began developing a severe headache around 2:00 pm and took naproxen. The headache continued and I went to bed early. When I woke in the middle of the night, I felt more sick than I have ever felt. I was sweating, also felt chilled, was nauseous, and my head pounded. I experienced these symptoms for most of the following day and had to stay in bed. After that, I felt weak and worn out, but did not need to stay in bed.
Fever post vaccine. I remained ill and after not getting better post vaccine. 4/13 I went to the dr.  with sore throat, cough, headache , fatigue. 4/19/21 Acute sepsis/tachycardia Sick/congestion, headaches, runny stool, shortness of breath continued
Patient passed away from chronic respiratory failure with cardiogenic shock 24 hours from 2nd dose of vaccine. Patient with longstanding history of pulmonary HTN and heart failure with desire for comfort care only.  Entering into VAERS out of abundance of caution.
Onset evening of flu shot-redness and swelling to site, tender.  No abscess, no fever, no streaking, no respiratory or other problems.  Treatment: Local heat, advil. Unable to contact person @ home.  Left messages.
Immediate soreness in area of vaccination. Additional inflammation and solidification of portion of muscle where vaccine was injected. Subsequent pain when utilizing muscle (pars acromialis).  The adverse events continue three years later.
Arm pain; Very low, depressed thoughts that are very much out of the ordinary; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Jun2021 at 09:45 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included colon cancer and depressive state. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Jun2021 at 16:00 the patient experienced very low, depressed thoughts that are very much out of the ordinary and arm pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the events very low, depressed thoughts that are very much out of the ordinary and arm pain was not recovered.   Follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
I noticed that in the past few days, my arm was still somewhat tender and achy, despite more than ten days passing since receiving the vaccine.  It was also a bit itchy.  Over the weekend, I did try to move my arm around a bit more and massage the injection site.  This morning, as I was about to get into the shower, I noticed in the mirror that I had a fairly large, splotchy rash on my right bicep, and somewhat on my tricep area.  My arm is no longer sore, but it is still a bit itchy.  I decided to take pictures of both of my arms to try to help keep track of my symptoms.
I was expecting to feel tired and dizzy and figured I would need a day off from work because I had that reaction after my 2nd shot on April 7, 2021. This time though, after my 3rd shot (booster), I started feeling chills with uncontrolled shivering and general fatigue that night. When I got up in the middle of the night to go to the bathroom as I often do, I do not remember passing out, but found myself on the bathroom floor wedged between the toilet and the wall. Again, I don't remember falling and this is the first time  I know to have passed out.
Severe fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Severe fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Severe fatigue). At the time of the report, FATIGUE (Severe fatigue) outcome was unknown.            No concomitant medication were reported. No treatment information was provided by the reporter.   Reporter did not allow further contact
Patient received dose of Janssen vaccine after receiving only one dose of Pfizer on 7/10/2021. No adverse effects were reported by client during her time within the vaccine clinic.
About 5 hours after vaccine, we started noticing unusual "tics" in our son. Sudden onset of excessive blinking and movements with his tongue/mouth. Both of these are new for him. The onset was quite obvious as this behavior had not been observed prior to this date.   He blinks very frequently and has a lot of hard blinks. With his tongue, he sticks it out a lot almost like a reptile. Lots of repetitive motion. He also randomly suddenly twists his tongue to the side. He doesn't seem too aware and the movements seem involuntary.
body aches, chills, nausea, vomiting, diarrhea, dizziness, headache, fatigue, and fever
Sore arm for two days. That's ALL, nothing more. THANK YOU for the opportunity to get this vaccine!
The patient experienced syncope/seizures on two occasions.  The first episode occurred on 9/23/07 in the P.M. after stepping out of the shower, resulting in an emergency room visit.  An EKG was performed and the patient was released with no identifiable diagnosis.  Two weeks later, the patient had another syncope/seizure episode.  This episode also occurred in the P.M., while at a party.  Because the patient is away from home in college, she was referred by the Medical Director to a local Neurologist.  The neurologist ordered the following test: 1) MRI Scan, 2) EEG, 3) ECHO and 4) Holter monitor.  All of the test results were benign.  To date, no explainable cause has been identified for the seizures. 11/13/08-records received for DOS 9/23/07-ED visit with C/O possible seizure dy prior. Has been dieting times 1 week. Headache. At ED felt fine. Assessment:Evaluation of seizure.
Hives all over body; itchy. No SOB/facial swelling/difficulty swallowing.
On 6/11/22 noticed left axillary swelling that extends into chest wall noticed the next morning following vaccination  the previous afternoon.
sore spot at the injection site; Initial information received on 04-Nov-2021 regarding an unsolicited valid Media non-serious case received from a consumer/non-health care professional.   This case involves adult patient (unknown age and gender) who had sore spot at the injection site (vaccination site pain) after receiving INFLUENZA VACCINE.  It was unknown if the patient had any medical history, concomitant disease or risk factor.  The patient's medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date: not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious sore spot at the injection site (vaccination site pain) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported "Got mine Tuesday. Painless and no side effects other than a sore spot at the injection site".  It was unknown if the patient experienced any additional symptoms/events.  It was unknown if there were lab data/results available.  It was not reported if the patient received a corrective treatment.  At time of reporting, the outcome was unknown for the reported event.  There will be no information available on the batch number for this case.
This spontaneous report received from a 15 years old female patient with colitis (mild). The patient was vaccinated  with dose 1, dose 2 and dose 3 GARDASIL on 12-AUG-2010, 12-OCT-2012 and 16-AUG-2011. No other co-suspects were reported. Concomitant medications included: LIALDA for colitis. In September 2011, the patient experienced nausea, dizziness, tremors, heat intolerance, night sweats, fainting, 4 inch ovarian cyst, upper right quadrant pain and anxiety (seeing therapist). The patient saw spots when she stood up. The patient sought medical attention from obstetrician/gynecologist. Colonoscopy was performed. The outcome of upper right quadrant pain, spots, anxiety, tremors, heat intolerance, night sweats, fainting, 4 inch ovarian cyst, dizziness and nausea was unknown. Additional information is not expected.
Hives Rash throughout body.  Treated with steroids prednisilone (6 days) and rash went away
States she has swelling, redness and tenderness "the size of a small orange" and that it is hot to touch, at the site where the chickenpox vaccine was given.
Raised, red welt half way around arm. Very hot and sensitive in same area also in underarm.
11/9/21-11/11/21: Rotate ibuprofen and acetaminophen for symptoms and fever management; Fever 100.5; Muscle aches- grade 3; Headache- grade 3; Fatigue- grade 3; Arthralgia- grade 3; Shivering- grade 3; 11/12/21- Muscle aches; Arthralgia
body aches; neck ache; joint pains; Fatigue; moderate-severe headache; low fever; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: ER8732) via an unspecified route of administration in the left arm on 25Mar2021 at 12:00 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history included Paget Schroetter -blood clot - right 1st rib resection from 2007 to 2009. The patient was allergic to sulphites, penicillin, quinolones, sulfanamide clarithromycin(UNKNOWN MANUFACTURER) and septocaine(UNKNOWN MANUFACTURER) . Prior to vaccination, the patient was not diagnosed with COVID-19. Since vaccination, the patient was not tested for COVID-19. On 25Mar2021 at 12:15, the patient experienced fatigue, moderate-severe headache, low fever 99.5F, neck/body aches and joint pains. The patient did not receive any treatment for the reported events. The clinical outcome of the events fatigue, moderate-severe headache, low fever, neck/body aches and joint pains were recovering at the time of this report.    No follow-up attempts possible. No further information expected.
headache; This is a spontaneous report from a contactable consumer or other non hcp (patient) from a Pfizer sponsored program COVAX Support. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot number was not reported), via an unspecified route of administration on 11Feb2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 11Feb2021, the patient experienced headache. Verbatim and Event Description: Patient received the first dose of Covid-19 vaccine today, 5-6 hours ago and she is experiencing headache. Asking if she can take Tylenol for the headache. Outcome of the event was unknown.  Follow-Up (PRD/SRD 02Apr2021): Follow-up attempts are completed. No further information is expected.
Myalgia & Diarrhea  Narrative:  Per supervisor report: "[3/12] Muscle Aches and 2 loose stools"   Other Relevant History:
Initial misuse report received from a non-healthcare professional on 18 September 2013 and on 21 March 2014. A patient under age of 65 years of unknown gender had received FLUZONE HD on an unknown date. No adverse event was reported. The list of documents held by sender: None.
Pain starting in left armpit approx 2 days after vaccination  Pain in left shoulder Burning and aching in left shoulder continuing still on 4/2/2021
Patient administered 0.5mL dose instead of the correct 0.25mL booster dose for their fourth dose in the series.
Intense Muscle/Nerve Pain. Pain spread to neck and unable to move neck, pain in shoulder blades and clicking noise when shoulders are moved in circular motion. Tingling in fingertips.
Acute joint pain; Chills; Headache; Soreness that went down into the opposite arm and radiated into her hand; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of ARTHRALGIA (Acute joint pain), CHILLS (Chills), HEADACHE (Headache) and VACCINATION SITE PAIN (Soreness that went down into the opposite arm and radiated into her hand) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) and BUDESONIDE for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced ARTHRALGIA (Acute joint pain), CHILLS (Chills), HEADACHE (Headache) and VACCINATION SITE PAIN (Soreness that went down into the opposite arm and radiated into her hand). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at a dose of 1 dosage form. On 26-Jan-2021, ARTHRALGIA (Acute joint pain), CHILLS (Chills), HEADACHE (Headache) and VACCINATION SITE PAIN (Soreness that went down into the opposite arm and radiated into her hand) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
AE: patient felt warm pain on the right arm after 1 minute of  vaccine administration. As per the patient, never  felt this kind of pain before. there was no numbness, no tingling. it did not hurt upon palpitation.  Treatment: patient was offered water to drink and kept under observation. Approximately 10 minutes after observation, patient symptoms improved.  Outcome: Patient was discharged to POV/Home.